XML 56 R53.htm IDEA: XBRL DOCUMENT v2.4.1.9
Loans Receivable (Details)
1 Months Ended 12 Months Ended 12 Months Ended
May 31, 2013
USD ($)
Dec. 31, 2014
USD ($)
loan
Dec. 31, 2013
USD ($)
Dec. 31, 2012
USD ($)
Dec. 31, 2014
Zensun [Member]
USD ($)
Dec. 31, 2014
SPIL China [Member]
USD ($)
Dec. 31, 2014
SciClone Pharmaceuticals (China) Ltd [Member]
CNY
Dec. 31, 2014
SciClone Pharmaceuticals (China) Ltd [Member]
USD ($)
Dec. 31, 2014
SPIL China and SciClone Pharmaceuticals (China) Ltd [Member
USD ($)
Sep. 30, 2014
Loan One [Member]
SPIL China [Member]
USD ($)
Dec. 31, 2014
Loan Two [Member]
SPIL China [Member]
USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]                      
Collateralized loan amount, maximum $ 12,000,000scln_CollateralizedLoanMaximumAmount       $ 12,000,000scln_CollateralizedLoanMaximumAmount
/ dei_LegalEntityAxis
= scln_ZensunMember
$ 11,750,000scln_CollateralizedLoanMaximumAmount
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= scln_SciclonePharmaceuticalsInternationalChinaHoldingLtdMember
1,550,000scln_CollateralizedLoanMaximumAmount
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= scln_SciclonePharmaceuticalsChinaLtdMember
       
Loan receivable   4,750,000us-gaap_NotesAndLoansReceivableNetNoncurrent       4,500,000us-gaap_NotesAndLoansReceivableNetNoncurrent
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= scln_SciclonePharmaceuticalsInternationalChinaHoldingLtdMember
1,550,000us-gaap_NotesAndLoansReceivableNetNoncurrent
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= scln_SciclonePharmaceuticalsChinaLtdMember
250,000us-gaap_NotesAndLoansReceivableNetNoncurrent
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= scln_SciclonePharmaceuticalsChinaLtdMember
  2,250,000us-gaap_NotesAndLoansReceivableNetNoncurrent
/ us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis
= scln_LoanOneMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= scln_SciclonePharmaceuticalsInternationalChinaHoldingLtdMember
2,250,000us-gaap_NotesAndLoansReceivableNetNoncurrent
/ us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis
= scln_LoanTwoMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= scln_SciclonePharmaceuticalsInternationalChinaHoldingLtdMember
Interest rate           7.50%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= scln_SciclonePharmaceuticalsInternationalChinaHoldingLtdMember
  7.50%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= scln_SciclonePharmaceuticalsChinaLtdMember
     
Expiration date           Sep. 26, 2017          
Commitment agreement, number of loan agreements   2scln_CommitmentAgreementNumberOfLoanAgreements                  
Collateralized loan, option to extend, period           2 years          
Term             66 months        
Interest and investment income   161,000scln_InvestmentIncomeInterestAndTermDepositInterest 85,000scln_InvestmentIncomeInterestAndTermDepositInterest 89,000scln_InvestmentIncomeInterestAndTermDepositInterest         100,000scln_InvestmentIncomeInterestAndTermDepositInterest
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= scln_SciclonePharmaceuticalsInternationalChinaHoldingLtdAndSciclonePharmaceuticalsChinaLtdMember
   
Loans receivable, fair value                 $ 5,200,000us-gaap_NotesReceivableFairValueDisclosure
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= scln_SciclonePharmaceuticalsInternationalChinaHoldingLtdAndSciclonePharmaceuticalsChinaLtdMember